Desensitization protocol to pomalidomide in a patient with cutaneous hypersensitivity: A case report

Gabriel Martínez-Orea1, Carlos Devesa-García1, Laura Puente-Romero1

  • 1Servicio de Farmacia, Hospital Universitario Sant Joan d'Alacant, Alicante, España.

Summary

Hypersensitivity reactions to pomalidomide, an immunomodulatory drug, can be managed. A desensitization procedure allowed a patient with refractory multiple myeloma to safely restart pomalidomide treatment.